Jerome Retzepter

Finance Business Partner, Associate Director - Rare Diseases at Alnylam Pharmaceuticals - Cambridge, Massachusetts, US

Jerome Retzepter's Colleagues at Alnylam Pharmaceuticals
Shakthi Rajah

Director - International Patient Discovery & Diagnostics Lead

Contact Shakthi Rajah

Mohana Suppiah

Clinical Trial Manager (Global)

Contact Mohana Suppiah

David Keller

Manager, Clinical Operations

Contact David Keller

Stephen Cieplik

Director, Integrated Delivery Networks

Contact Stephen Cieplik

Sean McNally

Business Account Executive

Contact Sean McNally

View All Jerome Retzepter's Colleagues
Jerome Retzepter's Contact Details
HQ
(617) 551-8200
Location
Zurich,Zurich,Switzerland
Company
Alnylam Pharmaceuticals
Jerome Retzepter's Company Details
Alnylam Pharmaceuticals logo, Alnylam Pharmaceuticals contact details

Alnylam Pharmaceuticals

Cambridge, Massachusetts, US • 2460 Employees
SaaS

ALNYLAM IS LEADING THE RNAi REVOLUTION™ Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, four more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases. We are a global and diverse company of 2,500+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-23), Science Magazine (2018-23), Fast Company (Best Workplaces for Innovators 2020-23) and LinkedIn (2024). We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America. See our social media community guidelines: https://bit.ly/2FcRhJy. Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861

Rna Therapeutics Innovative Treatments Ocular Disease Treatment
Details about Alnylam Pharmaceuticals
Frequently Asked Questions about Jerome Retzepter
Jerome Retzepter currently works for Alnylam Pharmaceuticals.
Jerome Retzepter's role at Alnylam Pharmaceuticals is Finance Business Partner, Associate Director - Rare Diseases.
Jerome Retzepter's email address is ***@alnylam.com. To view Jerome Retzepter's full email address, please signup to ConnectPlex.
Jerome Retzepter works in the SaaS industry.
Jerome Retzepter's colleagues at Alnylam Pharmaceuticals are Shakthi Rajah, Mohana Suppiah, David Keller, Danielle Chow, Stephanie Harris, Stephen Cieplik, Sean McNally and others.
Jerome Retzepter's phone number is (617) 551-8200
See more information about Jerome Retzepter